The last time I spoke about Praxis Precision Medicines, Inc. (PRAX), it was in a Seeking Alpha article entitled "Praxis: Still A 'Hold' Despite Interim Analysis Setback Of Ulixacaltamide." At that ...
The last time I spoke about Cogent Biosciences, Inc. (COGT), it was in a Seeking Alpha article entitled "Cogent: Several 2025 Readouts On Deck With Bezuclastinib Advancement". With respect to this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback